SCHEMBL10748221

SCHEMBL10748221

CC(C)(C)Nc1ncnc(NC(C)(C)C)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ LMNA P02545 2/20 0.52
▸ MAPT P10636 1/20 0.52
▸ CYP1A2 P05177 3/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ PDE4A P27815 1/20 0.45
▸ KMT2A Q03164 4/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ IDH2 P48735 2/20 0.39
▸ IDH1 O75874 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CDK4 P11802 1/20 0.38
▸ CCND1 P24385 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7057840 0.85 LMNA (0.50) SMN1; SMN2LMNAMAPTKMT2AMEN1
SCHEMBL8432702 0.84 SMN1; SMN2 (0.59) SMN1; SMN2LMNAMAPTCYP1A2CYP2C19
SCHEMBL5966376 0.82 NPSR1 (0.49) SMN1; SMN2LMNAMAPTCYP1A2CYP2C19
SCHEMBL9526292 0.81 TSHR (0.40) SMN1; SMN2LMNAMAPTCYP1A2CYP2C19
SCHEMBL11269602 0.81 GAA (0.38) SMN1; SMN2LMNAMAPTCYP1A2CYP2C19
SCHEMBL8464395 0.81 KMT2A (0.46) SMN1; SMN2LMNAMAPTCYP1A2CYP2C19
SCHEMBL10619199 0.80 SMN1; SMN2 (0.74) SMN1; SMN2LMNAMAPTCYP1A2CYP2C19
SCHEMBL5966347 0.79 SMN1; SMN2 (0.41) SMN1; SMN2LMNAMAPTCYP1A2CYP2C19
SCHEMBL11269609 0.78 KCNH3 (0.45) SMN1; SMN2LMNAMAPTCYP1A2CYP2C19
SCHEMBL11788223 0.73 PDE4A (0.37) SMN1; SMN2LMNAPDE4AKMT2ACDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0240854-A1 Bis-tert-butylamino-substituted 1,3,5-triazine derivatives, process for their preparation, medicaments containing these compounds, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-10-14 — — EP disclosed
Send feedback